BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26862856)

  • 1. Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
    Casaburi I; Cesario MG; Donà A; Rizza P; Aquila S; Avena P; Lanzino M; Pellegrino M; Vivacqua A; Tucci P; Morelli C; Andò S; Sisci D
    Oncotarget; 2016 Mar; 7(11):12651-61. PubMed ID: 26862856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.
    Xu S; Wang T; Song W; Jiang T; Zhang F; Yin Y; Jiang SW; Wu K; Yu Z; Wang C; Chen K
    Sci Rep; 2015 Aug; 5():13528. PubMed ID: 26314494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.
    Gang X; Wang G; Huang H
    Prostate; 2015 May; 75(6):561-72. PubMed ID: 25631036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
    Lanzino M; Maris P; Sirianni R; Barone I; Casaburi I; Chimento A; Giordano C; Morelli C; Sisci D; Rizza P; Bonofiglio D; Catalano S; Andò S
    Cell Death Dis; 2013 Jul; 4(7):e724. PubMed ID: 23846226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
    Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression.
    Hall RE; Birrell SN; Tilley WD; Sutherland RL
    Eur J Cancer; 1994; 30A(4):484-90. PubMed ID: 8018407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines.
    Garcia-Carpizo V; Ruiz-Llorente S; Sarmentero J; González-Corpas A; Barrero MJ
    Mol Cancer Res; 2019 Mar; 17(3):720-730. PubMed ID: 30606771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
    Rizza P; Barone I; Zito D; Giordano F; Lanzino M; De Amicis F; Mauro L; Sisci D; Catalano S; Dahlman Wright K; Gustafsson JA; Andò S
    Breast Cancer Res; 2014 Feb; 16(1):R21. PubMed ID: 24552459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.
    Feng J; Li L; Zhang N; Liu J; Zhang L; Gao H; Wang G; Li Y; Zhang Y; Li X; Liu D; Lu J; Huang B
    Oncogene; 2017 May; 36(20):2775-2790. PubMed ID: 27893717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
    Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
    Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.
    Lanzino M; Sisci D; Morelli C; Garofalo C; Catalano S; Casaburi I; Capparelli C; Giordano C; Giordano F; Maggiolini M; Andò S
    Nucleic Acids Res; 2010 Sep; 38(16):5351-65. PubMed ID: 20421209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen.
    Wolf DA; Herzinger T; Hermeking H; Blaschke D; Hörz W
    Mol Endocrinol; 1993 Jul; 7(7):924-36. PubMed ID: 8413317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
    Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
    Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bringing androgens up a NOTCH in breast cancer.
    Tarulli GA; Butler LM; Tilley WD; Hickey TE
    Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.
    Ahram M; Mustafa E; Zaza R; Abu Hammad S; Alhudhud M; Bawadi R; Zihlif M
    Cell Biol Int; 2017 Dec; 41(12):1345-1355. PubMed ID: 28816390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
    Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
    Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.